Previous close | 38.20 |
Open | 38.19 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 37.93 - 38.27 |
52-week range | 33.56 - 48.88 |
Volume | |
Avg. volume | 1,362,691 |
Market cap | 49.923B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 47.01 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.23 (0.60%) |
Ex-dividend date | 27 May 2024 |
1y target est | N/A |
Prestigious International Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market, today announced that Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has been sele
Press ReleaseVELIZY-VILLACOUBLAY, France — May 3, 2024 COMBINED GENERAL SHAREHOLDERS’ MEETING OF MAY 22, 2024 Availability of preliminary documents Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) informs its shareholders that its Combined Shareholders’ Meeting will be held on Wednesday, May 22, 2024 at 3:00 pm at Dassault Systèmes’ headquarters, 10 rue Marcel Dassault – 78140 Vélizy-Villacoublay. The preliminary notification stating the agenda and the draft resolutions was published in
Press ReleaseVELIZY-VILLACOUBLAY, France — May 2, 2024 DISCLOSURE OF TRADING IN OWN SHARES(Repurchase program decided by the General Meeting of Shareholders of May 24, 2023) Issuer: Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA)Type of securities: Ordinary sharesPeriod: April 26, 2024 Detailed information (presentation by day and by market and transaction-by-transaction details) can be consulted on the website of Dassault Systèmes: https://investor.3ds.com/regulated-information/permane